Skip to content

Correlation analysis between sleep monitoring related indexes and serum metabolic indexes and the effect of CPAP treatment

Relationship between ANGPTL3, angptl8 and glucose and lipid metabolism in patients with obstructive sleep apnea and its clinical significance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059401
Enrollment
Unknown
Registered
2022-04-29
Start date
2022-04-30
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea

Interventions

Group 1 :
Group 2:
Group 3:

Sponsors

The First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. OSA patients meet the criteria of the latest diagnostic guidelines, and the selected subjects did not drink alcohol, strong tea, coffee, cola, or use sedative and hypnotic drugs that affect sleep 24 hours before sleep monitoring; 2. Age > 18 years old, gender is not limited; 3. The medical records are complete and relevant examinations are accepted; 4. Willing to participate in this experiment after communication and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other types of sleep disorders; 2. Patients undergoing ENT surgery or positive airway pressure therapy; 3. Other endocrine diseases that affect glucose metabolism; 4. Those who are using drugs that affect body weight or lipid-lowering drugs; 5. Severe liver, kidney, heart and brain diseases; 6. Patients with malignant tumors, chemotherapy and immunosuppression; 7. Unable to cooperate with the assessor.

Design outcomes

Primary

MeasureTime frame
angiopoietin-like protein 3;angiopoietin-like protein 8;total cholesterol;Triglycerides;High density lipoprotein cholesterol, HDL-C;Low density lipoprotein cholesterol, LDL-C;Fasting blood glucose;Fasting insulin;Apnea hypopnea index;Minimum finger pulse oxygen saturation;Oxygen decrement index;

Secondary

MeasureTime frame
nesfatin-1;fat-specific serine protease inhibitors;

Countries

China

Contacts

Public ContactRen Shouan

The First Hospital of Shanxi Medical University

renshouan@163.com+86 13934519061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026